Still very sceptical. If the deal was really as good as a lot of you guys think, the share price would have risen accordingly. Upcoming capital raising is what’s holding the share price back IMO
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025